Logo

USC, Baylor Use ParAllele Kit for Lupus, Flu Vaccine Studies

Apr 27, 2005

NEW YORK , April 27 (GenomeWeb News) -  ParAllele Bioscience today said that researchers at the University of Southern California and the Baylor College of Medicine will use its Immune-Inflammation SNP-genotyping panel to perform association studies on lupus and respiratory pathogens.

 

Researchers from USC will be spearheading the association studies on childhood-onset lupus, ParAllelle said. Baylor will be using the panel to study the genetic basis of variability in immune response to the flu vaccine, and to study human response to respiratory pathogens in general.

 

The panel is currently offered through a service by ParAllele and is being commercialized as a product by Affymetrix as part of its MegAllele Human Immune-Inflammation Genotyping Kit.

Breaking News
The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.